Memorial Sloan Kettering’s new tower on East 67th Street will be 76 feet shorter than previously planned, the cancer center said, even after winning the approval of the Council to build higher ...

Memorial Sloan Kettering collected and curated the data to train the model, while Mount Sinai's computational researchers did much of the machine learning work, Morris said.

A New York City cancer center just received two sizable grants to fund research into pediatric cancer. Memorial Sloan ...

Memorial Sloan Kettering Cancer Center in New York City saw its operating loss reach $453.3 million in the nine months ended Sept. 30, despite receiving $100 million in federal relief aid ...

MSK researchers learn that  immune cells are the unexpected source of a protein called FAS-ligand, which has undermined the ...

By combining clinical and genomic data, physician-scientists from Memorial Sloan Kettering Cancer Center (MSK) developed a tool that could help improve predictions of how people with hormone ...

Dr. Jonathan Rosenberg, chief attending physician at Memorial Sloan Kettering Cancer Center, discusses coach Deion Sanders’ ...

In October, Memorial Sloan Kettering’s chief executive, Dr. Craig B. Thompson, resigned from the boards of Charles River Laboratories, an early-stage research company, and drugmaker Merck.

Dr. Feigin has been with Memorial Sloan Kettering for 22 years, where she most recently served as interim chief of the service line, according to a Jan. 13 news release from the cancer center.

The Society of Memorial Sloan Kettering (MSK) held its first Palm Beach luncheon, raising over $280,000. The event supported the MSK Cancer Health Equity Research and Care Initiative, which aims ...

Connecticut-based Hartford HealthCare has collaborated with Memorial Sloan Kettering Cancer Center in New York to open a new cancer center in Fairfield, Connecticut, that's being called the first of ...

2. Three Fractionated SRS Treatments Versus One MSK is a participating institution in a large, phase 3 trial testing fractionated SRS versus standard SRS in patients with intact brain metastases ...